
MS-4 @LoyolaHealth, Clemson '21, Heart Failure Collaboratory, Inova Health System @hfcollaboratory
Joined July 2021
- Tweets65
- Following49
- Followers75
- Likes247
Matt Dimond retweeted
Huge congratulations again to the site-based research award recipients! Well deserved for their dedication to their respective fields 👏👏 👏
Matt Dimond retweeted
SIMULTANEOUS PUBLICATION OUT NOW🗣️
Click the link below to read Yasmire’s paper on clinical research’s unsung HEROES and the importance of rewarding site-based research ⬇️
ahajournals.org/doi/10.1161/…
@dranulala @mfiuzat @coconnormd @MariellJessup @yasmireshardae
Matt Dimond retweeted
Me and @Matt_Dimond1 -so proud of you and what you have accomplished! @LoyolaStritch Catherine Kim plans to follow in his footsteps !
Matt Dimond retweeted
Congratulations @Matt_Dimond1 on completion of his research on factors associated with better BP control among physician patient panels. Turns out BP measurement method is a lot! @LoyolaStritch @LoyolaParkinson #stalbertsday @LoyolaChicago
Do BP control Quality Improvement (QI) initiatives work??
NEW @LoyolaHealth:
⬆️ physician AOBP measurement and ⬆️ 30-day patient follow up when BP is elevated = ⬆️ rates of physician #HTN control!!
Huge thanks to @kramer_holly for her leadership on this project! #HTN #AOBP
Congratulations @Matt_Dimond1 on completion of his research on factors associated with better BP control among physician patient panels. Turns out BP measurement method is a lot! @LoyolaStritch @LoyolaParkinson #stalbertsday @LoyolaChicago
Matt Dimond retweeted
Feasibility and safety of apixaban in patients with an LVAD was evaluated in DOAC LVAD study. Results reported in #JACCHF
@PalakShahMD @coconnormd
Matt Dimond retweeted
Replying to @Matt_Dimond1 @hfcollaboratory @coconnormd @mfiuzat @IsabellaCavagna @robmentz @vbluml @mpsotka
Incredible mentorship from @mfiuzat and all star ✨✨✨interns make for an incredible program @hfcollaboratory
Matt Dimond retweeted
How can we call attention to the lack of diversity in clinical trials at a Congressional level?
@meghakgupta presents at #ACC2024 on the HFC Letter to Congress to reconsider demographic legislation and the HFC recommendations to enhance underrepresented enrollment in HF trials
Matt Dimond retweeted
How can we utilize community organizations to improve diversity in clinical trials?
@iamyasdoll Presenting on how HFC and National Pan-Hellenic Councils can bring awareness to Black patients and underserved communities of the critical lack of diversity in HF clinical trials.
Matt Dimond retweeted
Great insights from @IsabellaCavagna at #ACC2024 today about the impact of #ClinicalTrial demographics on early adoption of breakthrough #MedTech.
Now available in @JACCJournals: sciencedirect.com/science/ar…
US Safety Info: bit.ly/3TVOnfL
Matt Dimond retweeted
Happy birthday to HFC Intern @meghakgupta 🎊🥳 What a great way to celebrate at your first ACC conference!
Matt Dimond retweeted
#SimPub in @JACCJournals
Does HF trial enrollment contribute to underutilization of therapies among diverse groups in clinical practice?
HFC Intern @IsabellaCavagna presents on Clinical Trial Inclusion manuscript out now at the link below🔗
sciencedirect.com/science/ar…
Matt Dimond retweeted
💡NEW State-of-the-Art Review on HFC’s efforts to train the next generation of members and create a standardized approach to data reporting, DMC conduct, & new member training to help address the growing demand for experienced DMC members
Read below ⬇️
doi.org/10.1016/j.jchf.2024.…
Matt Dimond retweeted
HFC Special Focus meeting starting now…
@coconnormd @mfiuzat @hmkyale @SnehaShahJain setting the stage for the meeting with the importance of #AI and how the HF community can embrace this groundbreaking technology
Matt Dimond retweeted
And that’s a wrap! @PalakShahMD closes #THT2024 with a BANG exploring promise & potential of #microRNA in #transplant #rejection @coconnormd @mpsotka @vbluml @ISHVnews @InovaHealth @InovaCVfellows @KiranKhush1
Matt Dimond retweeted
Replying to @docbhardwaj @JACCJournals @hfcollaboratory @mfiuzat @JavedButler1 @DukeHFDoc @Nikhil15 @slumberbell @JTThibs @adrianjdasilva @BiykemB
#HFmrEF doesn’t exist: from a clinical context it adds unneeded confusion, from a research context it is an oversimplification of the continuous spectrum of LVEF.
Matt Dimond retweeted
The @ISHVnews Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study -- a Featured Late-Breaker at #THT
To be presented by @PalakShahMD @crfheart @crfconferences
Matt Dimond retweeted
@PalakShahMD shares #LBCT results #DOAC #LVAD pilot study #THT2024 Time now 4 pivotal RCT on anticoagulation in durable #MCS? @coconnormd @mpsotka @iyadisseh @MaryLoobyPharmD @ISHVnews @InovaHealth @InovaCVfellows
Matt Dimond retweeted
A new model for training the next generation of clinical investigators, gap year HFC interns , Congrats ! – at Washington, DC
HFC Interns have FOUR abstracts accepted for presentation at the @ACCinTouch conference this spring in Atlanta, GA. Don’t forget to stop by the poster sessions 🎉
Specific times of presentations still to come
@iamyasdoll @MeghaGu86063358 @IsabellaCavagna #ACC24
Matt Dimond retweeted
In #JACCHF REVIEW TOPIC OF THE MONTH, @Matt_Dimond1, @mpsotka, et al present results of @HFCollaboratory review of role of LVEF in categorization of HF, and provide recommendations for future of HF phenotyping
jacc.org/doi/10.1016/j.jchf.…








































